T16012
Marizomib
TargetMol
DESCRIPTION
Marizomib (ML858) is a novel irreversible brain-permeable proteasome inhibitor that inhibits CT-L (β5), CT-T-laspase-like (C-L, β1), and trypsin-like (T-L, β2) 20S proteasomes with IC50s of 3.5, 28, and 430 nM, respectively.
DETAILS
- Cas: 437742-34-2
- Purity: 98.03%
- Smiles: [C@@H](O)([C@]12[C@](C)([C@@H](CCCl)C(=O)N1)OC2=O)[C@]3(CCCC=C3)[H]
- Category: Compound
- Molecular Weight: 313.78
- Molecular Formula: C15H20ClNO4
Lead Time: 4 - 5 weeks
Sign in to view pricingEquivalent Items
| ... Loading